HK69883A - Therapeutic compounds containing beta-lactams - Google Patents

Therapeutic compounds containing beta-lactams

Info

Publication number
HK69883A
HK69883A HK698/83A HK69883A HK69883A HK 69883 A HK69883 A HK 69883A HK 698/83 A HK698/83 A HK 698/83A HK 69883 A HK69883 A HK 69883A HK 69883 A HK69883 A HK 69883A
Authority
HK
Hong Kong
Prior art keywords
lactams
compounds containing
therapeutic compounds
containing beta
beta
Prior art date
Application number
HK698/83A
Other languages
English (en)
Inventor
Roger John Ponsford
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3892/76A external-priority patent/GB1574906A/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of HK69883A publication Critical patent/HK69883A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
HK698/83A 1976-01-31 1983-12-15 Therapeutic compounds containing beta-lactams HK69883A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3892/76A GB1574906A (en) 1976-01-31 1976-01-31 Therapeutic compounds containing - lactams
GB1900276 1976-05-08

Publications (1)

Publication Number Publication Date
HK69883A true HK69883A (en) 1983-12-23

Family

ID=26238678

Family Applications (1)

Application Number Title Priority Date Filing Date
HK698/83A HK69883A (en) 1976-01-31 1983-12-15 Therapeutic compounds containing beta-lactams

Country Status (31)

Country Link
US (2) US4428958A (xx)
JP (1) JPS5295689A (xx)
AR (3) AR214306A1 (xx)
AT (1) AT351675B (xx)
AU (1) AU515736B2 (xx)
BG (1) BG27751A3 (xx)
CA (1) CA1089471A (xx)
CH (2) CH637655A5 (xx)
CS (1) CS196341B2 (xx)
DD (1) DD128196A5 (xx)
DE (1) DE2702954A1 (xx)
DK (1) DK146940C (xx)
ES (1) ES455404A1 (xx)
FI (1) FI63581C (xx)
FR (1) FR2339616A1 (xx)
GR (1) GR62544B (xx)
HK (1) HK69883A (xx)
IE (1) IE44759B1 (xx)
IL (1) IL51267A (xx)
KE (1) KE3303A (xx)
LU (1) LU76668A1 (xx)
MX (1) MX4950E (xx)
NL (1) NL7700892A (xx)
NO (1) NO770279L (xx)
NZ (1) NZ183117A (xx)
PH (1) PH13924A (xx)
PT (1) PT66071B (xx)
RO (1) RO69712A (xx)
SE (1) SE441359B (xx)
SU (1) SU645583A3 (xx)
YU (1) YU10777A (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
GB2004541B (en) * 1977-09-16 1982-05-12 Beecham Group Ltd Ethers of clavulanic acid a process for their preparation and pharmaceutical compositions containing them
EP0008899B1 (en) * 1978-09-05 1982-09-15 Beecham Group Plc Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
EP0018203B1 (en) * 1979-04-21 1983-03-02 Beecham Group Plc Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions
NZ193687A (en) * 1979-05-17 1982-12-21 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds
US5958462A (en) * 1997-05-23 1999-09-28 Mclean; Linsey Therapeutic bath salts and method of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039673A (en) 1973-10-30 1977-08-02 Bayer Aktiengesellschaft Penicillins and cephalosporins and their production
US3983113A (en) 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials

Also Published As

Publication number Publication date
LU76668A1 (xx) 1977-06-28
US4428958A (en) 1984-01-31
MX4950E (es) 1983-01-12
GR62544B (en) 1979-05-07
IL51267A (en) 1979-12-30
YU10777A (en) 1982-06-30
PT66071A (en) 1977-02-01
AR216555A1 (es) 1979-12-28
NL7700892A (nl) 1977-08-02
NZ183117A (en) 1979-10-25
CH637655A5 (de) 1983-08-15
BG27751A3 (en) 1979-12-12
DD128196A5 (de) 1977-11-02
RO69712A (fr) 1980-07-15
KE3303A (en) 1983-08-05
ATA53477A (de) 1979-01-15
PH13924A (en) 1980-11-04
FR2339616A1 (fr) 1977-08-26
ES455404A1 (es) 1978-05-01
IE44759L (en) 1977-07-31
DK146940B (da) 1984-02-20
FI770295A (xx) 1977-08-01
FR2339616B1 (xx) 1980-04-11
CA1089471A (en) 1980-11-11
DK146940C (da) 1984-07-30
CS196341B2 (en) 1980-03-31
DK38577A (da) 1977-08-01
US4505894A (en) 1985-03-19
AR216925A1 (es) 1980-02-15
PT66071B (en) 1978-06-23
SE7700946L (sv) 1977-08-01
SE441359B (sv) 1985-09-30
NO770279L (no) 1977-08-02
CH638529A5 (de) 1983-09-30
AU515736B2 (en) 1981-04-30
JPS5295689A (en) 1977-08-11
FI63581C (fi) 1983-07-11
SU645583A3 (ru) 1979-01-30
AR214306A1 (es) 1979-05-31
DE2702954A1 (de) 1977-08-04
IL51267A0 (en) 1977-03-31
AT351675B (de) 1979-08-10
IE44759B1 (en) 1982-03-24
JPS613349B2 (xx) 1986-01-31
AU2177077A (en) 1978-08-03
FI63581B (fi) 1983-03-31

Similar Documents

Publication Publication Date Title
IL48824A0 (en) Thc-type compounds
JPS52125197A (en) Transshexahydroopyridooindole compound
JPS5297994A (en) Betaalactummcontaining compounds
JPS5317639A (en) Hexakisazo compounds
KE3303A (en) Therapeutic compounds containing beta-lactams
GB1539364A (en) 11-deoxy-11-oxaprostaglandin compounds
SG3383G (en) 21-halogenopregnane compounds
JPS52156899A (en) Compound
JPS52111590A (en) Novel cephalospoline compounds
ZA775065B (en) Anti-protozoal compounds
ZA77258B (en) Therapeutic compounds containing beta-lactams
JPS52102227A (en) Haloalkylphosphate compounds
ZA772175B (en) Oxothia compounds
ZA777335B (en) Pharmaceutical compounds
JPS5285216A (en) Azamethineemetal complex compounds
JPS5297990A (en) Cephalospoline compounds
AU2650677A (en) Substituted triazoles
JPS52125158A (en) Oxothia compound
JPS52100491A (en) Cephalospoline compounds
GB1542784A (en) Arylorganobromosilicone compounds
CY1211A (en) Azatetracyclic compounds
JPS5318555A (en) Compounds
ZA772988B (en) Triazolopyridinium compounds
JPS5298735A (en) Pyrazoling compounds
JPS5297991A (en) Cephalospoline compounds